Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
In this study, mice were immunized nasally with surface protein antigen of Streptococcus mutans serotype c (PAc) and a nontoxic A subunit mutant of cholera toxin (mCT) E112K, as a mucosal adjuvant. Immunization with PAc and mCT elicited significant PAc-specific secretory IgA in saliva and in nasal secretions. Antibody-forming cell (AFC) analysis confirmed the antibody (Ab) titers by revealing significant numbers of PAc-specific IgA AFCs in the submandibular gland and nasal passages. Furthermore, CD4(+) T cells from cervical lymph nodes exhibited significant proliferative responses when restimulated with PAc in vitro. Importantly, mice that were nasally immunized with PAc plus mCT E112K exhibited significantly reduced oral colonization by S. mutans. These results show that nasal administration of PAc and mCT E112K is potentially an effective mucosal vaccine against dental caries and reduces the colonization of S. mutans in the oral cavity.
Saito
M
M
Department of Clinical Pathology, Nihon University School of Dentistry at Matsudo, Chiba, Japan.
Otake
S
S
Ohmura
M
M
Hirasawa
M
M
Takada
K
K
Mega
J
J
Takahashi
I
I
Kiyono
H
H
McGhee
J R
JR
Takeda
Y
Y
Yamamoto
M
M
D000276:Adjuvants, Immunologic; D000281:Administration, Intranasal; D000818:Animals; D000942:Antigens, Bacterial / Q000008:administration & dosage / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D001426:Bacterial Proteins / Q000008:administration & dosage / Q000276:immunology*; D001428:Bacterial Vaccines / Q000008:administration & dosage; D002772:Cholera Toxin / Q000235:genetics / Q000276:immunology*; D003731:Dental Caries / Q000517:prevention & control*; D018928:Immunity, Mucosal; D007070:Immunoglobulin A / Q000032:analysis; D051379:Mice; D008807:Mice, Inbred BALB C; D012703:Serotyping; D013290:Streptococcal Infections / Q000517:prevention & control*; D013295:Streptococcus mutans / Q000235:genetics / Q000276:immunology*; D016896:Treatment Outcome; D014611:Vaccination / Q000379:methods
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D007070:Immunoglobulin A; D002772:Cholera Toxin